| scholarly article | Q13442814 |
| P2093 | author name string | Berrin Demirbaş | |
| Erman Cakal | |||
| Mesut Ozkaya | |||
| Başak Cakal | |||
| Yalçin Aral | |||
| Selma Karaahmetoğlu | |||
| Rüştü Serter | |||
| P2860 | cites work | Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism | Q31831306 |
| Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease | Q31898591 | ||
| Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism | Q32027005 | ||
| Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey | Q32063031 | ||
| The Colorado thyroid disease prevalence study | Q33891706 | ||
| Subclinical hypothyroidism is mild thyroid failure and should be treated | Q34401022 | ||
| Atherosclerosis and the coagulation system | Q38713518 | ||
| Epidemiology of fibrinogen | Q40553935 | ||
| Homocysteine, folate, vitamin B12, and transcobalamins in patients undergoing successive hypo- and hyperthyroid states | Q43571658 | ||
| Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment | Q43714084 | ||
| TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). | Q43766458 | ||
| Risk factors for cardiovascular disease in women with subclinical hypothyroidism | Q44049866 | ||
| Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? | Q44133436 | ||
| Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy | Q44551983 | ||
| Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey | Q44557484 | ||
| Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism | Q44651441 | ||
| Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism | Q44721798 | ||
| Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism. | Q45146169 | ||
| Homocysteine concentrations in subclinical hypothyroidism | Q45156481 | ||
| Thyroid functions and serum lipids in older women: a population-based study. | Q45960643 | ||
| The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism | Q46371917 | ||
| The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism | Q46629465 | ||
| Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. | Q51555922 | ||
| Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration | Q60662462 | ||
| Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy | Q68574969 | ||
| Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina | Q70202660 | ||
| Primary haemostasis in thyroid disease | Q71700941 | ||
| Vitamin status and intake as primary determinants of homocysteinemia in an elderly population | Q72305071 | ||
| Relationship between thyroid hormones and fibrinogen levels | Q73356707 | ||
| Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study | Q73462518 | ||
| Plasma total homocysteine levels during short-term iatrogenic hypothyroidism | Q73555570 | ||
| Plasma total homocysteine levels in hyperthyroid and hypothyroid patients | Q74082039 | ||
| Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism | Q78215707 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 431-435 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Journal of Korean Medical Science | Q24039955 |
| P1476 | title | Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients | |
| P478 | volume | 22 |
| Q34770181 | Association between plasma homocysteine status and hypothyroidism: a meta-analysis |
| Q42340155 | Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer |
| Q37738172 | Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension |
| Q52615620 | Folic acid alleviates oxidative stress and hyperhomocysteinemia involved in testicular dysfunction of hypothyroid rats. |
| Q36958693 | Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study. |
| Q35878747 | Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells |
| Q42643965 | The effect of L-thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism |
Search more.